Schmitt Felix C F, Schneider Martin, Mathejczyk William, Weigand Markus A, Figueiredo Jane C, Li Christopher I, Shibata David, Siegel Erin M, Toriola Adetunji T, Ulrich Cornelia M, Ulrich Alexis B, Boutin Sébastien, Gigic Biljana
Department of Anesthesiology, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Department of General, Visceral and Transplant Surgery, Heidelberg University Hospital, 69120 Heidelberg, Germany.
Life (Basel). 2021 Mar 16;11(3):246. doi: 10.3390/life11030246.
Changes in the gut microbiome have already been associated with postoperative complications in major abdominal surgery. However, it is still unclear whether these changes are transient or a long-lasting effect. Therefore, the aim of this prospective clinical pilot study was to examine long-term changes in the gut microbiota and to correlate these changes with the clinical course of the patient. Methods: In total, stool samples of 62 newly diagnosed colorectal cancer patients undergoing primary tumor resection were analyzed by 16S-rDNA next-generation sequencing. Stool samples were collected preoperatively in order to determine the gut microbiome at baseline as well as at 6, 12, and 24 months thereafter to observe longitudinal changes. Postoperatively, the study patients were separated into two groups-patients who suffered from postoperative complications ( = 30) and those without complication ( = 32). Patients with postoperative complications showed a significantly stronger reduction in the alpha diversity starting 6 months after operation, which does not resolve, even after 24 months. The structure of the microbiome was also significantly altered from baseline at six-month follow-up in patients with complications ( = 0.006). This was associated with a long-lasting decrease of a large number of species in the gut microbiota indicating an impact in the commensal microbiota and a long-lasting increase of . The microbial composition of the gut microbiome shows significant changes in patients with postoperative complications up to 24 months after surgery.
肠道微生物群的变化已被证实与腹部大手术的术后并发症有关。然而,这些变化是暂时的还是长期的影响仍不清楚。因此,这项前瞻性临床试点研究的目的是检查肠道微生物群的长期变化,并将这些变化与患者的临床病程相关联。方法:总共对62例接受原发性肿瘤切除的新诊断结直肠癌患者的粪便样本进行了16S-rDNA下一代测序分析。术前收集粪便样本以确定基线时的肠道微生物群,此后在6、12和24个月时收集样本以观察纵向变化。术后,研究患者被分为两组——有术后并发症的患者(n = 30)和无并发症的患者(n = 32)。有术后并发症的患者在术后6个月开始α多样性显著降低,即使在24个月后仍未恢复。并发症患者在6个月随访时微生物群结构也与基线相比有显著改变(P = 0.006)。这与肠道微生物群中大量物种的长期减少有关,表明对共生微生物群有影响,以及[此处原文可能有误,推测应为某一特定微生物或菌群名称]的长期增加。肠道微生物群的微生物组成在术后并发症患者中直至术后24个月都有显著变化。